121 related articles for article (PubMed ID: 3227156)
1. Adrenal vein and arterial levels of catecholamines and immunoreactive metenkephalin in canine endotoxin shock and their response to naloxone.
Watson JD; Varley JG; Bouloux PM; Tomlin SJ; Rees LH; Besser GM; Hinds CJ
Res Exp Med (Berl); 1988; 188(5):319-28. PubMed ID: 3227156
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine and cardiovascular responses to high-dose corticosteroid therapy in canine endotoxin shock.
Watson JD; Varley JG; Tomlin SJ; Medbak S; Perry L; Bouloux PM; Rees LH; Besser GM; Hinds CJ
Res Exp Med (Berl); 1988; 188(5):329-39. PubMed ID: 3227157
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of neuropeptide tyrosine Y (NPY) are increased in human sepsis but are unchanged during canine endotoxin shock despite raised catecholamine concentrations.
Watson JD; Sury MR; Corder R; Carson R; Bouloux PM; Lowry PJ; Besser GM; Hinds CJ
J Endocrinol; 1988 Mar; 116(3):421-6. PubMed ID: 3351430
[TBL] [Abstract][Full Text] [Related]
4. Biochemical characterization of circulating Met-enkephalins in canine endotoxin shock.
Watson JD; Varley JG; Tomlin SJ; Medbak S; Rees LH; Hinds CJ
J Endocrinol; 1986 Nov; 111(2):329-34. PubMed ID: 3794585
[TBL] [Abstract][Full Text] [Related]
5. Effects of hemorrhage and naloxone on adrenal release of methionine-enkephalin and catecholamines in halothane anesthetized dogs.
Gaumann DM; Yaksh TL; Dousa MK; Tyce GM; Lucas DL; Hench VS
J Auton Nerv Syst; 1987 Nov; 21(1):29-41. PubMed ID: 3440817
[TBL] [Abstract][Full Text] [Related]
6. Effects of intravascular volume expansion on the cardiovascular response to naloxone in a canine model of severe endotoxin shock.
Evans SF; Hinds CJ; Varley JG
Br J Pharmacol; 1984 Oct; 83(2):443-8. PubMed ID: 6487903
[TBL] [Abstract][Full Text] [Related]
7. Cryptic Met-enkephalin in adrenal and portal vein during splanchnic artery occlusion shock in cats.
Gaumann DM; Yaksh TL; Lucas DL
Neurosci Lett; 1990 Aug; 116(3):387-92. PubMed ID: 2243619
[TBL] [Abstract][Full Text] [Related]
8. Adrenal and intestinal secretion of catecholamines and neuropeptides during splanchnic artery occlusion shock.
Gaumann DM; Yaksh TL
Circ Shock; 1988 Dec; 26(4):391-407. PubMed ID: 3214933
[TBL] [Abstract][Full Text] [Related]
9. Effects of naloxone and thyrotropin-releasing hormone on plasma catecholamines, corticosterone, and arterial pressure in normal and endotoxemic rats.
Long JB; Lake CR; Reid AA; Holaday JW
Circ Shock; 1986; 18(1):1-10. PubMed ID: 3080257
[TBL] [Abstract][Full Text] [Related]
10. Release of opioid peptides in canine hemorrhagic hypotension: effects of naloxone.
Brückner UB; Lang RE; Ganten D
Res Exp Med (Berl); 1984; 184(3):171-8. PubMed ID: 6089283
[TBL] [Abstract][Full Text] [Related]
11. Naloxone requires circulating catecholamines to attenuate the cardiovascular suppression of endotoxic shock.
Allgood SC; Gurll NJ; Reynolds DG
J Surg Res; 1988 Jan; 44(1):73-81. PubMed ID: 3336212
[TBL] [Abstract][Full Text] [Related]
12. Adrenal vein catecholamines and met-enkephalin during staged hemorrhage and naltrexone administration in cats.
Gaumann DM; Yaksh TL; Dousa MK; Tyce GM
Circ Shock; 1989 Feb; 27(2):139-54. PubMed ID: 2539919
[TBL] [Abstract][Full Text] [Related]
13. Increased adrenal secretion of norepinephrine and epinephrine after endotoxin and its reversal with corticosteroids.
Prager RL; Dunn EL; Seaton JF
J Surg Res; 1975 Apr; 18(4):371-5. PubMed ID: 1095827
[No Abstract] [Full Text] [Related]
14. A new canine model of endotoxin shock.
Evans SF; Hinds CJ; Varley JG
Br J Pharmacol; 1984 Oct; 83(2):433-42. PubMed ID: 6435710
[TBL] [Abstract][Full Text] [Related]
15. Involvement of endogenous opiates in glucose-stimulated hyperinsulinism of canine endotoxin shock. Inhibition by naloxone.
Merrill GA; Anderson JH
Diabetes; 1987 May; 36(5):585-91. PubMed ID: 2952536
[TBL] [Abstract][Full Text] [Related]
16. Naloxone and methylprednisolone sodium succinate enhance sympathomedullary discharge in patients with septic shock.
Hughes GS
Life Sci; 1984 Dec; 35(23):2319-26. PubMed ID: 6390057
[TBL] [Abstract][Full Text] [Related]
17. Plasma catecholamines during endotoxin infusion in conscious unrestrained rats: effects of adrenal demedullation and/or guanethidine treatment.
McKechnie K; Dean HG; Furman BL; Parratt JR
Circ Shock; 1985; 17(1):85-94. PubMed ID: 3902274
[TBL] [Abstract][Full Text] [Related]
18. Preferential secretion of adrenaline or noradrenaline by the cat adrenal in vivo in response to different stimuli.
Feuerstein G; Gutman Y
Br J Pharmacol; 1971 Dec; 43(4):764-75. PubMed ID: 5152027
[TBL] [Abstract][Full Text] [Related]
19. Plasma catecholamine levels in porcine Escherichia coli septicaemia and following treatment with buprenorphine or naloxone.
Donaldson MD; Vesey CJ; Bouloux PM; Watson JD; Besser GM; Hinds CJ
Circ Shock; 1993 Mar; 39(3):169-77. PubMed ID: 8453740
[TBL] [Abstract][Full Text] [Related]
20. Effect of an opiate antagonist (naloxone) and an agonist/antagonist (nalbuphine) in primate hemorrhagic shock: relationship to catecholamine release.
McIntosh TK; Palter M; Grasberger R; Vezina R; Yeston NS; Egdahl RH
Circ Shock; 1985; 17(4):313-25. PubMed ID: 4092345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
